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1145-126 Left Ventricular Assist Device Implantation Induces 
Neo-Neurogenesis Accompanied by Neo-Angiogenesis 
in the Nonscarred Myocardium in Patients With Heart 
Failure
Porur Somasundaram, Ruth Anway, Jennifer Hall, Inder Anand, Leslie Miller, Y. 
Chandrashekhar, University of Minnesota, Minneapolis, MN, VA Medical Center, 
Minneapolis, MN
Background: End stage heart failure (esHF) is associated with reduced blood vessel and
nerve density. LVAD implantation reverses ventricular myocyte & fibrous tissue remodel-
ing but it is not clear if it can also optimize neo-angiogenesis and repopulate myocardial
nerves.
Hypothesis: LVAD implantation will re-innervate the heart along with neo-angiogenesis
while reversing ventricular remodeling.
Methods: Myocardial nerve growth (immunostaining with PGP for total nerves, GAP43 +
tyrosine hydroxylase for new sympathetic nerves) and neo-angiogenesis (vWF+Ki-67
staining) was measured in the non-scar myocardium at LVAD implant and at transplanta-
tion in 6 patients with esHF (4 ischemic and 2 non-ischemic).
Results: Time between LVAD and transplant 151-681 days. LVAD implantation signifi-
cantly improved total & new blood vessel density (p<0.05) while inducing reverse remod-
eling. This was accompanied by increased new sympathetic innervation in the same
region. Conclusion: LVAD implantation facilitates neo-angiogenesis. This may help in the
process of reverse remodeling seen after LVAD use. LVAD also induces new nerve
growth in non-scar myocardium. It significance in terms of arrhythmic potential, especially
in patients being considered for LVAD explantation, needs to be determined. 
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1146-105 The Prognostic Significance of Exercise-Induced Atrial 
Arrhythmias
Thomas J. Bunch, Krishnaswamy Chandrasekaran, Bernard J. Gersh, Stephen C. 
Hammill, David O. Hodge, Akbar H. Khan, Douglas L. Packer, Patricia A. Pellikka, Mayo 
Clinic, Rochester, MN
Background: Although stress-induced atrial arrhythmias are common during exercise
testing, there is a paucity of data regarding the correlation with underlying heart disease
and cardiovascular outcomes. Atrial arrhythmias may reflect underlying left atrial enlarge-
ment and diastolic dysfunction, which are prognostic of mortality. We hypothesized these
stress- induced arrhythmias are associated with long-term adverse cardiac events.
Methods: Exercise echocardiography was performed in 5,375 patients (age 61 ± 12
years) with known or suspected coronary artery disease. An abnormal result was defined
as exercise-induced atrial fibrillation/flutter (AF), supraventricular tachycardia (SVT), or
atrial ectopy (AE).
Results: Three hundred and eleven patients (5.8%) died (132 (2.5%) cardiac causes)
over a period of 3.1 ± 1.7 years. In addition, 193 patients (3.6%) experienced a MI, and
531 (9.9%) required revascularization. During exercise testing, 1272 (24%) developed
AE, 185 (3.4%) SVT, and 43 (0.8%) AF. The 5-year cardiac death rate was not statisti-
cally different between groups [none (3.8%), AE (4.3%), SVT (3.7%), AF (0%), p=0.43].
However, the 5-year rate of MI was significantly different between groups [none (5.7%),
AE (8.3%), SVT (0%), AF (9.0%), p=0.005]. The 5-year rate of revascularization between
groups was not significantly different [none (14.2%), AE (17.0%), SVT (11.8%), AF
(14.8%), p=0.50]. A composite of all 5-year adverse endpoints was similar between
groups [none (22.7%), AE (27.8%), SVT (17.7%), AF (25.7%), p=0.10]. In stepwise mul-
tivariate analysis, AE was not predictive of myocardial infarction when taking into account
traditional clinical variables and exercise test results.
Conclusion: In this large cohort of patients, the occurrence of atrial ectopy was predic-
tive of an increased risk of myocardial infarction. However, this association did not persist
after adjustment for clinical and exercise variables known to predict adverse long-term
cardiovascular outcomes. The rate of long-term cardiac death or revascularization was
not influenced by the development of stress-induced atrial arrhythmias.
1146-106 Does Abatement of Ventricular Ectopy With Exercise 
Mean a Better Prognosis?
Obadah Alchekakie, Michael S. Lauer, Mina K. Chung, Cleveland Clinic Foundation, 
Cleveland, OH
Background: Among patients with frequent ventricular ectopy at rest, it is believed that an
abatement of ventricular ectopy during exercise testing predicts a lower risk of death.
Methods: We followed 920 consecutive patients (age=62+11, 78% male) with frequent
ventricular ectopy at rest just before undergoing exercise testing and who had no history
of heart failure, valve disease, pacemakers, or atrial fibrillation.Frequent ventricular
ectopy before, during, and after exercise was defined as more than 7 ventricular prema-
ture depolarizations per minute, frequent couplets, any triplets, bigeminy, trigeminy, non-
sustained or sustained ventricular tachycardia, or ventricular fibrillation. Abatement was
considered present if there was there was no frequent ventricular ectopy during exercise.
Results: There were 214 patients (23%) who had an abatement of ventricular ectopy dur-
ing exercise. During 7 years of follow-up there were 142 deaths. Patients with abatement
of ventricular ectopy were more likely to be women (33% vs. 19%, P<0.0001) and less
likely to have a history of coronary bypass grafting (18% vs. 27%, P=0.005), but there
were no marked differences in age (61 vs. 62), diagnosis of coronary disease (46% vs.
44%), or reduced physical fitness (29% vs. 27%). Seven-year death rates tended to be
slightly lower among patients with abatement compared to those without (14.3% vs.
17.3%, P=0.87). After accounting for age, gender, standard risk factors, medications,
resting electrocardiographic findings, functional capacity, and heart rate recovery, abate-
ment did not predict a lower risk of death (adjusted hazard ratio 1.03, 95% confidence
interval 0.70-1.54, P=0.87).Conclusion: Among patients with frequent ventricular ectopy
at rest, abatement of ectopy during exercise does not predict a lower risk of death.
1146-107 Severe Frequent Ventricular Ectopy After Exercise as a 
Predictor of Death in Patients With Advanced Systolic 
Heart Failure
James O. O'Neill, James B. Young, Claire E. Pothier, Michael S. Lauer, Cleveland Clinic 
Foundation, Cleveland, OH
Background: Although ventricular ectopy during recovery after exercise predicts death
in patients without heart failure, its prognostic importance in patients with advanced heart
failure is unknown.
Methods: Systematic electrocardiographic data during rest, exercise and recovery were
gathered on 2123 consecutive Cleveland Clinic Foundation patients with left ventricular
systolic ejection fraction < 35% who were referred for symptom limited metabolic tread-
mill exercise testing.Severe ventricular ectopy was defined as the presence of ventricular
triplets, sustained or non-sustained ventricular tachycardia, ventricular flutter, polymor-
phic ventricular tachycardia or ventricular fibrillation. The primary end point was all cause
mortality, with censoring for interval cardiac transplantation.
Results: Of 2,123 patients, 140 (7%) had severe ventricular ectopy in recovery. There
were 561 deaths during follow-up (median among survivors 2.9 years). Severe ventricu-
lar ectopy during recovery was associated with an increased risk of death compared to
patients without severe ectopy (3-year death rates 37% vs. 22%, hazard ratio 1.76, 95%
CI 1.32 - 2.34, P<0.0001). After adjustment for ventricular ectopy at rest and during exer-
cise, peak oxygen uptake, and other potential confounders, severe ventricular ectopy in
recovery remained predictive of death (adjusted hazard ratio 1.48; 95% confidence inter-
val 1.10-1.97; p=0.0089), whereas ventricular ectopy during exercise was not predictive.
Conclusion: Severe ventricular ectopy during recovery after exercise is predictive of
increased mortality in patients with severe heart failure.
1146-108 Association of Triglyceride to High-Density Lipoprotein 
Cholesterol Ratio With Heart Rate Recovery in Healthy 
Adults
Mehdi H. Shishebor, Byron J. Hoogwerf, Michael S. Lauer, Cleveland Clinic Foundation, 
Cleveland, OH
Background: Insulin resistance is associated with altered autonomic function. An atten-
uated decrease in heart rate immediately after exercise (or heart rate recovery) predicts
all-cause mortality and is believed to reflect decreased parasympathetic activity. Utilizing
TG/HDL-C concentration as a marker of insulin resistance we sought to assess the asso-
ciation between insulin resistance and heart rate recovery.
Methods: Our study population included 4963 healthy adults who participated in the
Lipid Research Clinics’ Prevalence Study and who underwent exercise testing. Heart rate
recovery was considered abnormal if < 42 beats per minute two minutes into recovery.
Fasting blood specimens were drawn for lipid profiles and blood glucose.
Results: Individuals in the highest quartile of TG/HDL-C had significantly higher preva-
lence of abnormal heart rate recovery (HRR) (40% vs. 30%; multivariable adjusted prev-
alence ratio, 1.18; 95% CI 1.01-1.39; P = 0.04). When considered as a continuous
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variable, an increase in one standard deviation (0.37) of TG/HDL-C ratio was associated
with a greater likelihood of an abnormal HRR, even after adjusting for over 20 covariates
(adjusted odds ratio, 1.16; 95% CI, 1.07-1.25; P < 0.001). During 12 years of follow-up,
there were 284 deaths. In age and sex-adjusted analysis, participants with an abnormal
HRR and high TG/HDL-C ratio had significantly higher mortality than those with a normal
HRR and high TG/HDL-C ratio (hazard ratio = 1.49; 95% CI 1.08-2.04; P = 0.015).
Conclusions: Heart rate recovery is associated with TG/HDL-C ratio and identifies
patients with insulin resistance who are at increased risk of death.
1146-109 The Effect of Leisure-Time Physical Activity on 
Inflammation Markers: The ATTICA Study
Demosthenes B. Panagiotakos, Christos Pitsavos, Christina Chrysohoou, John Lentzas, 
Christodoulos Stefanadis, A' Cardiology Clinic, Athens, Greece
BACKGROUND: Physical activity is associated with a reduced risk for coronary heart
disease (CHD), although the exact mechanisms remain unknown.As CHD is increasingly
seen as an inflammatory process, it is reasonable to hypothesize that physical activity
reduces CHD risk by modifying inflammatory processes. METHODS: The ATTICA study
is a population -based cohort that has randomly enrolled 2282 cardiovascular disease
free individuals, stratified by age group, from the greater area of Athens, during 2001-
2002. Of them, 1128 were men (48 ± 14 years old, range: 18 – 86) and 1154 women (47
± 14 years old, range: 18 - 88). We assessed the relationship between self reported
physical activity status and inflammation, thrombogenic markers as indicated by C-reac-
tive protein, amyloid-A, fibrinogen and white blood cell counts, after taking into account
the effect of several demographic, clinical and biochemical characteristics of the partici-
pants. RESULTS: Compared with persons that reported sedentary life, those who
defined as highly physical active had 33%, lower concentrations of C-reactive protein (1.5
± 1.4 vs. 0.9 ± 1.3 mg/dl, p = 0.020), 10% of white blood cells (6.9 ± 1.9 vs. 6.2 ± 1.7
counts, p = 0.012), 17% of amyloid-A (5.1 ± 5.4 vs. 4.2 ± 5.3, p = 0.059), and 3% of fibrin-
ogen (328 ± 145 vs. 318 ± 74 mg/dl, p = 0.445), after controlling for several potential con-
founders. CONCLUSIONS: Physical activity is associated with lower concentrations of C-
reactive protein, white blood cells and other inflammation and thrombogenic markers.
These findings suggest that the inflammation process and consequently atherosclerotic
disease can be attenuated by increased physical activity.
1146-110 Chronotropic Incompetence as a Predictor of Death 
Among Patients Taking Beta-Blockers
Mohammed Khan, Claire E. Pothier, Michael S. Lauer, Cleveland Clinic Foundation, 
Cleveland, OH
Background: Chronotropic incompetence, or an inability to increase heart rate during
exercise, independently predicts death. Whether it predicts death in patients taking beta-
blockers is not known.
Methods: We followed for a mean of 5.2 years 7456 patients (age 60+11, 70% men) who
were taking either metoprolol or atenolol and were referred for symptom-limited exercise
treadmill testing between 1990 and 2002. Chronotropic response was defined as the per-
cent of heart rate reserve used, that is (peak heart rate – resting heart rate)/(maximum
predicted heart rate – resting heart rate). A value of < 59%, corresponding to the lowest
quartile, was defined as abnormal.
Results: There were 3868 patients (52%) taking atenolol and 3588 (49%) taking meto-
prolol. There were 644 deaths. Patients with chronotropic incompetence had a higher
mortality risk (6-year death rates 14% vs. 7%, hazard ratio 2.1, 95% CI 1.8 – 2.5,
P<0.0001). After adjusting for age, gender, resting heart rate, standard risk factors, other
medications, exercise capacity, and heart rate recovery, chronotropic incompetence pre-
dicted death (adjusted hazard ratio 1.4, 95% CI 1.1-1.6, P=0.0005). The association of
chronotropic incompetence with death was present irrespective of which drug was taken
or the number of half-lives elapsed since the last dose. Even among patients in the low-
est quartile of half-lives elapsed (< 0.9), chronotropic incompetence predicted death
(10% vs. 6%, hazard ratio 2.0, 95% CI 1.4 – 2.9, P<0.0001).
Conclusion: Among patients taking beta-blockers, chronotropic incompetence is predic-
tive of death.
1146-111 Exercise Cardiopulmonary Predictors of Major Clinical 
Events in Advanced Heart Failure
Carl J. Lavie, Richard V. Milani, Mandeep R. Mehra, Ochsner Clinic Foundation, New 
Orleans, LA
Background: Numerous studies indicate that exercise cardiopulmonary tests (CPX) pre-
dict prognosis of chronic systolic heart failure (HF). We investigated the interactions of
various clinical and CPX variables in assessing prognosis in patients with advanced HF.
Methods: CPX was performed in 98 consecutive advanced HF patients (NYHA class III-
IV, mean EF 20%) followed for 18 ± 12 months for major clinical events (cardiovascular
death or urgent transplantation). We examined CPX variables associated with clinical
events by conducting univariate and multivariate analyses and assessed several stan-
dard variables to predict prognosis.
Results: Compared with 20 patients with major clinical events, the 78 patients without
events had significantly higher percent of predicted peak VO2 (63.7 ± 19.8% vs. 54.2
±13.0%, p < 0.02), peak VO2 corrected for lean body weight (20.0 ± 6.6 vs. 16.7 ± 4.5 cc/
kg/min lean, p < 0.02), O2–pulse (10.9 ± 4.5 vs. 9.0 ± 2.5 cc/beat, p < 0.02), body fat
adjusted O2–pulse (15.0 ± 5.9 vs. 11.8 ± 3.6 cc/beat, p < 0.01), and lower VE/VCO2
(34.7 ± 7.9 vs. 41.5 ± 7.2, p < 0.01). Peak VO2 (14.5 ± 5.1 vs. 12.9 ± 3.9 cc/kg/min, p =
0.12), peak heart rate and peak systolic blood pressure were statistically similar in both
groups. In multivariate analysis, a non-ischemic cardiomyopathy was the strongest inde-
pendent predictor of event-free survival (chi-square 8.3, p < 0.01), followed by body fat
adjusted O2-pulse (chi-square 7.1, p < 0.01) and peak VO2 lean (chi-square 3.8, p =
0.05). The “Mancini” cut-off for peak VO2 (14 ml/kg/min) was particularly poor for prog-
nostic stratification (16% vs 25% events; p=NS); this was improved considerably by using
O2–pulse (cut-off 10 ml/beat;13% vs 28% events, p=0.05), peak VO2 lean (cut-off 19 ml/
kg/min; 9% vs 30% events; p<0.01) and especially by O2 pulse lean (cut-off 14 ml/
beat;9% vs 31% events, p<0.01).
Conclusions: This investigation suggests that while unadjusted peak VO2 is unreliable in
segregating risk in advanced HF, a combination of clinical and exercise cardiopulmonary
variables, particularly body fat adjusted O2-pulse and peak VO2, more robustly predict
clinical outcome in this clinical syndrome.
1146-112 Systolic Blood Pressure During Recovery Is Related to 
the Risk of Acute Myocardial Infarction in Middle-Aged 
Men
Jari A. Laukkanen, Sudhir Kurl, Rainer Rauramaa, Jukka T. Salonen, University of 
Kuopio, Kuopio, Finland
Background: We assessed the association of systolic blood pressure (SBP) after exer-
cise with the risk of an acute myocardial infarction in middle-aged men with no prior his-
tory of coronary heart disease. Limited information currently exists on the association of
the SBP during recovery and the risk of acute myocardial infarction.
Methods: SBP was measured every two minutes during and 2 minutes after a progres-
sive cycle ergometer exercise test in a representative population-based sample of 1789
Finnish men (age 42-61 years), 243 of whom were using antihypertensive medications.
During an average follow-up period of 12.7 years, 191 acute myocardial infarctions
occurred.
Results: An incremental rise of 10 mmHg per minute in SBP after exercise (relative
risk=1.12, 95 % CI 1.04 to 1.20, p=0.001) was associated with the risk of acute myocar-
dial infarction among men not on antihypertensive medications, after adjustment for age,
alcohol consumption, smoking, serum lipids, diabetes mellitus, body mass index, physi-
cal fitness, heart rate and ischemic ECG findings and resting SBP. Men with elevated
SBP of over 198 mmHg after exercise had a 2.10-fold (95 % CI 1.26 to 3.41, p=0.004)
risk for an acute myocardial infarction as compared to those with SBP less than 165
mmHg, after adjustment for age, other risk factors and resting SBP. High SBP after exer-
cise relative to maximal SBP was also related to the risk of AMI.
Conclusions: Systolic blood pressure during recovery period was risk predictor for acute
myocardial infarction among middle-aged men not receiving antihypertensive medica-
tions. This measure can provide incremental predictive value for an acute myocardial inf-
arction to elevated resting SBP.
1146-113 A Pretest Score Used in Patients With Suspected 
Coronary Disease Referred for Pharmacologic Stress 
Testing Stratifies Well According to Cardiac Death but 
Not All-Cause Mortality
Anthony P. Morise, West Virginia University School of Medicine, Morgantown, WV
Background: Patients with suspected coronary disease referred for pharmacologic
stress testing (Pharm) have a higher all-cause mortality (ACM) than those referred for
exercise testing. In exercise test patients, a pretest score has been shown to stratify well
according to ACM. Methods: To determine how well the pretest score stratified patients
referred for Pharm, we analyzed 3999 consecutive ambulatory patients with symptoms of
suspected coronary disease who presented for their initial stress evaluation between
1995 and 2001. Mean follow-up time was 4.4+1.7 years. Endpoints were cardiac death
(CD) and ACM. Variables considered in the pretest score were age, sex, symptoms, and
risk factors. Analysis was performed using the Kaplan-Meier method and contingency
table analysis. Results: There were 259 deaths (6.5%; 1.5%/year) of which 37% were
CDs (2.3%; 0.5%/year). Within the 1036 Pharm patients, there were 165 deaths (16%;
3.6%/year) of which 38% were CDs (6.1%; 1.4%/year). Within the 2963 exercise
patients, there were 94 deaths (3.2%; 0.7%/year) of which 34% were CDs (1.0%; 0.2%/
year). Patients were stratified by the pretest score into either low or intermediate-high
groups (see table). ** = p<0.0001, * = p<0.01 by Kaplan-Meier.Conclusion: Patients who
underwent Pharm were stratified by the pretest score according to both ACM and CD.
However, low risk Pharm patients were at low risk for CD, but not ACM.
Exercise Pharm
ACM CD ACM CD
Low 12/1294 5/1294 10/213 1/213
Percent 0.9 0.4 4.7 0.5
Annualized % 0.2 0.1 1.1 0.1
Intermediate-High 82/1669 27/1669 155/823 62/823
Percent 4.9** 1.6* 18.8** 7.5**
Annualized % 1.1 0.4 4.3 1.7
